Interestingly, IBV was more effective than IAV at expanding cross-reactive CD8+ T-cells, suggesting that infection history may play a role in determining patterns of cross-reactivity and that selection of peptide sequences that promote the greatest cross-reactivity is a consideration for universal influenza T-cell vaccines. The gene discussed is CD8A; the disease is infection.